MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 03 2023
23 03 2023
Historique:
received:
17
09
2022
accepted:
20
03
2023
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
We systematically analyzed the kinetics of tumor regression, the impact of residual lesions on disease control and the applicability of the Lugano classification in follow-up MRI of orbital non-Hodgkin lymphomas that were irradiated with photons. We retrospectively analyzed a total of 154 pre- and post-irradiation MRI datasets of 36 patients with low-grade, Ann-Arbor stage I, orbital non-Hodgkin lymphomas. Patients with restricted conjunctival involvement were excluded. Lymphoma lesions were delineated and volumetrically analyzed on T1-weighted sequences. Tumor residues were present in 91.2% of all cases during the first six months after treatment. Volumetric partial response rates (> 50% volume reduction) were 75%, 69.2%, and 50% at 12-24 months, 36-48 months and > 48 months after the end of treatment. The corresponding complete response (CR) rates according to the Lugano classification were 20%, 23.1% and 50%. During a median clinical follow-up of 37 months no significant differences in progression free survival (PFS) rates were observed between the CR and non-CR group (p = 0.915). A residual tumor volume below 20% of the pretreatment volume should be expected at long-term follow-up beyond one year after radiotherapy.
Identifiants
pubmed: 36959374
doi: 10.1038/s41598-023-31941-w
pii: 10.1038/s41598-023-31941-w
pmc: PMC10036339
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4792Informations de copyright
© 2023. The Author(s).
Références
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):650-4
pubmed: 24521680
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1387-93
pubmed: 20950950
Eur Radiol. 2021 Dec;31(12):8925-8936
pubmed: 34021390
Asia Pac J Clin Oncol. 2019 Dec;15(6):358-363
pubmed: 31264373
Radiother Oncol. 2009 Feb;90(2):236-41
pubmed: 18950885
Hematol Oncol. 2022 Dec;40(5):922-929
pubmed: 35857866
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):228-33
pubmed: 16503386
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):11-31
pubmed: 25863750
EJNMMI Res. 2019 Nov 21;9(1):99
pubmed: 31754896
Eur Radiol. 2019 Jan;29(1):202-212
pubmed: 29948084
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Ocul Oncol Pathol. 2017 Sep;3(3):181-187
pubmed: 29134184
Ann Hematol. 2015 Jul;94(7):1185-93
pubmed: 25728714
Lancet Oncol. 2014 Apr;15(4):457-63
pubmed: 24572077
Cancer. 2003 Aug 15;98(4):865-71
pubmed: 12910532
Br J Radiol. 2022 Feb 01;95(1130):20210635
pubmed: 34919440
EClinicalMedicine. 2018 Oct 17;4-5:32-42
pubmed: 31193655
Int J Oncol. 2020 Feb;56(2):417-429
pubmed: 31939615
Anticancer Res. 2020 Jul;40(7):4041-4046
pubmed: 32620650
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):86-91
pubmed: 19632068
Clin Nucl Med. 2016 Nov;41(11):837-843
pubmed: 27648705
JAMA Ophthalmol. 2014 Jul;132(7):851-8
pubmed: 24763920
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1382-91
pubmed: 14630277
Eur J Ophthalmol. 2022 Sep;32(5):3092-3096
pubmed: 34318737
Leuk Lymphoma. 2015 May;56(5):1266-70
pubmed: 25356924
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e659-66
pubmed: 21640514
Radiology. 2010 Aug;256(2):565-74
pubmed: 20656841
Radiother Oncol. 2001 May;59(2):139-44
pubmed: 11325441
Anticancer Res. 2013 Dec;33(12):5575-8
pubmed: 24324100
J Magn Reson Imaging. 2015 Dec;42(6):1646-55
pubmed: 25952024
Br J Haematol. 2011 Jan;152(1):72-80
pubmed: 21083656
Clin Cancer Res. 2015 Jun 1;21(11):2506-13
pubmed: 25733598
Blood. 2017 Jan 19;129(3):324-332
pubmed: 27789481
Radiother Oncol. 2011 Jul;100(1):86-92
pubmed: 21664710
Blood. 2022 Jan 13;139(2):240-244
pubmed: 34525196
Am J Ophthalmol. 2019 Mar;199:44-57
pubmed: 30419193
Cancer. 1987 Aug 1;60(3):407-13
pubmed: 3594379